Russell Frank Company’s TherapeuticsMD TXMD Stock Holding History

Russell Frank Company’s Portfolio TXMD Stock Details TXMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q1	$944K	Buy	2,950 +132	+5%	+$45K	﹤0.01%	2206
2015 Q4	$1.53M	Buy	2,818 +823	+41%	+$304K	﹤0.01%	1992
2015 Q3	$584K	Sell	1,995 -662	-25%	-$235K	﹤0.01%	2428
2015 Q2	$1.04M	Buy	+2,657	New	+$937K	﹤0.01%	2294
2014 Q2	–	Sell	-4,437	Closed	-$1.4M	–	2852
2014 Q1	$1.4M	Buy	4,437 +2,289	+107%	+$729K	﹤0.01%	1931
2013 Q4	$705K	Buy	2,148 +2,140	+26,750%	+$469K	﹤0.01%	2214
2013 Q3	$1K	Buy	+8	New	+$967	﹤0.01%	3401

Other funds holding TXMD

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

GGHC

Gilder Gagnon Howe & Co New York $8.34B AUM 46.58% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Russell Frank Company's TXMD Position: Q1 2016 in Review

Russell Frank Company increased its TherapeuticsMD (TXMD) stake by 4.7% in Q1 2016, buying an estimated $45K and bringing the position to 2,950 shares worth $944K. The position accounts for ﹤0.01% of the portfolio, ranked #2206.

Russell Frank Company first reported a position in TXMD in Q3 2013 and has held it in 7 quarters since. The position peaked at $1.53M in Q4 2015. 128 funds tracked by Wall St. Rank hold TXMD as of Q1 2016.

Russell Frank Company held 2,950 shares of TherapeuticsMD worth $944K as of Q1 2016.
Russell Frank Company bought 132 TherapeuticsMD shares in Q1 2016, an estimated $45K.
TherapeuticsMD made up ﹤0.01% of Russell Frank Company's portfolio in Q1 2016, its #2206 holding.
Russell Frank Company first reported a position in TherapeuticsMD in Q3 2013 and has held it in 7 quarters since.
Russell Frank Company's TherapeuticsMD position peaked at $1.53M in Q4 2015.
128 funds tracked by Wall St. Rank held TherapeuticsMD as of Q1 2016.

Based on Russell Frank Company's 13F filing for Q1 2016, filed 29 Apr 2016.